SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Progress Note 7 — Focused Visit (Care-plan review) — Zora Neale Hurston — True-date frame: synthetic events are moved into the patient's historical lifetime. Codes, instruments, and treatments remain modern and are anachronistic.

PatientZora Neale Hurston
Date of birth1891-01-07
IdentifiersMRN HR-ML040-SYN-TD; SSN (made up) 000-40-6213
Document date1958-10-19
AuthorLorraine Abernathy-Osei, MD
CustodianSt. Posthumous Health Center

Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.

Chief Complaint

Seven-month review: blood pressure, heart failure and screening results. [S]

History of Present Illness

Ms. Hurston returns five weeks after her annual wellness visit. She is substitute teaching two or three days a week and finishing a chapter of her new book. She walks to the bus without stopping and has had no lightheadedness, chest pain or swelling. Her home blood pressure average is 122/74. Her drug plan with Extra Help now supplies all five medicines in 90-day fills. Her screening results: the stool test (FIT) was negative, the mammogram was normal, the hepatitis C antibody was negative, and the bone density scan showed osteopenia (lowest T-score -1.6 at the femoral neck) with a ten-year risk of hip fracture below the level at which medicine is advised. The optometrist found mild hypertensive changes in the retinas without bleeding or swelling. She would like her zoster and Tdap vaccines today. [S]

ElementDetail
Home blood pressureAverage 122/74 mmHg
FunctionNYHA class I to II; teaching two or three days a week
ScreeningFIT, mammogram and hepatitis C negative; osteopenia, below the treatment threshold
EyesMild hypertensive retinopathy; no hemorrhage or swelling
KCCQ-1278

Review of Systems

SystemResultFinding
CardiovascularNegativeNo chest pain, palpitations or edema
NeurologicalNegativeNo headache, lightheadedness, weakness, numbness, speech or vision change
MusculoskeletalNegativeNo falls

3 systems reviewed. [S]

Medications

MedicationFrequencyRouteDatesStatusEvidence
Amlodipine 5 mg oral tablet, one tablet every morningOne tablet every morningOral route1958-03-09activeS
Chlorthalidone 25 mg oral tablet, one-half tablet (12.5 mg) every morningOne-half tablet every morningOral route1958-03-09activeS
Dapagliflozin 10 mg oral tablet, one tablet daily; pause on days of vomiting, diarrhea or not eating or drinkingOne tablet daily, with sick-day rulesOral route1958-03-23activeS
Atorvastatin 20 mg oral tablet, one tablet dailyOne tablet dailyOral route1958-03-23activeS
Spironolactone 25 mg oral tablet, one-half tablet (12.5 mg) dailyOne-half tablet dailyOral route1958-04-06activeS

Allergies and Intolerances

AllergyReactionStatusEvidence
No known allergyactiveS

Vital Signs

DateMeasureValueUnitProvenance
1958-10-19Body height165cmS
1958-10-19Body weight81.2kgS
1958-10-19Body mass index (BMI) [Ratio]29.8kg/m2S
1958-10-19Systolic blood pressure124mm[Hg]S
1958-10-19Diastolic blood pressure74mm[Hg]S
1958-10-19Heart rate70/minS
1958-10-19Respiratory rate16/minS
1958-10-19Body temperature36.5CelS
1958-10-19Oxygen saturation in Arterial blood by Pulse oximetry98%S

Results

DateMeasureValueUnitReference rangeFlagProvenance
1958-10-19Sodium [Moles/volume] in Serum or Plasma139mmol/L135-145 mmol/LNormalS
1958-10-19Potassium [Moles/volume] in Serum or Plasma4.3mmol/L3.5-5.1 mmol/LNormalS
1958-10-19Creatinine [Mass/volume] in Serum or Plasma0.92mg/dL0.59-1.04 mg/dLNormalS
1958-10-19Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 1953)/1.73 sq M68mL/min/{1.73_m2}>=60 mL/min/1.73 m²NormalS
1958-10-19Glucose [Mass/volume] in Serum or Plasma96mg/dL70-99 mg/dLNormalS
1958-10-19Magnesium [Mass/volume] in Serum or Plasma2mg/dL1.6-2.6 mg/dLNormalS
1958-10-19Overall summary score [KCCQ-12]78{score}S

Physical Exam

Vital signs recorded on 1958-10-19; see the Vital Signs section. [S]

SystemFinding
GeneralWell; blood pressure 124/74, pulse 70; weight 81.2 kg
NeckJugular venous pressure not raised
CardiovascularRegular rhythm; soft S4
RespiratoryClear
ExtremitiesNo edema

Problems

ProblemClinical statusVerificationCodeProvenance
Very high blood pressure at intake (178/104 and 174/102 mmHg) with morning headaches for two months, without signs of a hypertensive emergency; not previously diagnosed; ambulatory monitoring to confirmresolvedconfirmed R03.0S — Synthetic presenting problem, resolved when ambulatory monitoring and the echocardiogram established the diagnosis at the second visit. Not a claim about her real blood pressure.
Breathlessness on exertion for three months (walking to the school, carrying groceries) with mild ankle swelling by evening; cause to be determinedresolvedconfirmed R06.09S — Synthetic presenting problem, resolved into the heart failure diagnosis at the second visit.
Hypertensive heart disease with heart failure: stage 2 hypertension confirmed by 24-hour ambulatory monitoring (mean 158/96 mmHg, non-dipping at night), with concentric left ventricular hypertrophy on ECG and echocardiogram; synthetic modern episode linked to the hypertensive heart disease recorded as her cause of deathactiveconfirmed I11.0S — Synthetic modern diagnosis made at the second visit; the 1960 cause of death remains D.
Heart failure with preserved ejection fraction (ejection fraction 62%), NYHA class II, with grade II diastolic dysfunction and an enlarged left atriumactiveconfirmed I50.32S — Synthetic modern diagnosis confirmed by echocardiogram and cardiology at the second visit.
Food insecurity: food runs short at the end of most months (Hunger Vital Sign positive)activeconfirmed Z59.41S — Synthetic social need anchored to her documented poverty.
Low and irregular income from substitute teaching and newspaper writing, with Original Medicare but no drug coverage; medicine costs a barrieractiveconfirmed Z59.6S — Synthetic social need anchored to her documented low income in the 1950s.
Orthostatic hypotension with lightheadedness on standing, from volume depletion in early summer heat on a diuretic, spironolactone and an SGLT2 inhibitor; no fall or faint; resolved after two days off those medicines and more fluidresolvedconfirmed I95.1S — Synthetic intercurrent problem at an unscheduled visit; it follows from the treatment plan and the climate and does not echo a documented illness.

Assessment and Plan

Protocol monitoring: items the monitoring protocol calls for at this visit. [S]

DomainMeasureIntervalStatusDetail
ExaminationBlood pressure in the clinic (seated, average of two readings, large cuff)Every visitCompleted today124/74 mmHg
ExaminationOut-of-office blood pressure (ambulatory at diagnosis; home readings when treatment changes)At diagnosis and with each treatment changeCompleted todayHome average 122/74 mmHg
ExaminationWeight, volume status (jugular venous pressure, edema, lungs) and NYHA classEvery visitCompleted today81.2 kg; jugular venous pressure not raised; no edema; NYHA I to II
LaboratoryMetabolic panel (sodium, potassium, creatinine and eGFR) and magnesiumEvery three to six months when stableCompleted todaySodium 139, potassium 4.3, creatinine 0.92 mg/dL (eGFR 68), magnesium 2.0
SurveyKCCQ-12 heart failure health statusAt diagnosis, then every three to six monthsCompleted today78
LaboratoryLipid panelFour to twelve weeks after starting a statin; then yearlyUp to dateLDL 76 mg/dL at the eight-week review; next at one year
LaboratoryUrine albumin-to-creatinine ratioYearlyUp to date22 mg/g at intake; due at one year
LaboratoryHemoglobin A1cYearlyUp to date5.6% at intake; due at one year
ImagingECG and echocardiogramAt diagnosis; repeat only with unexplained clinical changeNot indicatedStable; no unexplained change
SurveyDepression screen (PHQ-2, then PHQ-9 if positive)YearlyUp to datePHQ-2 0 at the wellness visit
ExaminationEye examination for hypertensive retinopathyYearlyUp to dateDilated optometry examination since the wellness visit: mild hypertensive retinopathy without hemorrhage or swelling
Self-managementSelf-care: daily weights, less salt, sick-day rules and the BE FAST stroke signsEvery visitCompleted todayWeighs daily; heat plan through the summer; BE FAST reviewed
Medication safetyMedicine costs and coverage (generics, 90-day fills, patient assistance, Extra Help, Medicare Savings Program)Every visitCompleted todayAll five medicines through her drug plan with Extra Help, in 90-day fills
Self-managementFood accessEvery visitCompleted todayFood lasts the month

Goal progress:

Immunizations given today: Recombinant zoster vaccine, dose 1 of 2; Tetanus, diphtheria, and acellular pertussis vaccine (Tdap) [S]

Guideline basis: 2025 AHA/ACC/AANP/AAPA/ABC/ACCP/ACPM/AGS/AMA/ASPC/NMA/PCNA/SGIM Guideline for the Prevention, Detection, Evaluation and Management of High Blood Pressure in Adults (2025); 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure (2022); CMID: Clinical Monitoring Intelligence Database, hypertension and heart failure monographs (2026); Signs and Symptoms of Stroke (2026); Osteoporosis to Prevent Fractures: Screening (2025); Adult Immunization Schedule by Age (2026)

Follow-up: Zoster dose 1 and Tdap given today; second zoster dose in two to six months. Review in three months with a metabolic panel. Cardiology review at six months from consultation. Call 911 for any BE FAST sign. [S]